Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
Ángela Rojas, María del Rosario García-Lozano, Antonio Gil‐Gómez, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 2, pp. 356-362
Open Access | Times Cited: 11

Showing 11 citing articles:

Biotransformed bear bile powder ameliorates diet-induced nonalcoholic steatohepatitis in mice through modulating arginine biosynthesis via FXR/PXR-PI3K-AKT-NOS3 axis
Shan Jiang, Xiaolu Wei, Yan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115640-115640
Open Access | Times Cited: 14
The mitochondrial genome-encoded peptide MOTS-c interacts with Bcl-2 to alleviate nonalcoholic steatohepatitis progression
Huanyu Lu, Linni Fan, Wenli Zhang, et al.
Cell Reports (2024) Vol. 43, Iss. 1, pp. 113587-113587
Open Access | Times Cited: 4
Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
Teresa C. Delgado, Javier de las Heras, Maria Luz Martínez‐Chantar
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 14
Role of ammonia and glutamine in the pathogenesis and progression of metabolic dysfunction‐associated steatotic liver disease: A systematic review
Basile Njei, Yazan A. Al‐Ajlouni, Prince A. Ameyaw, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1788-1808
Closed Access | Times Cited: 2
Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer
Alaa Elmetwalli, Aly Nageh, Amany I. Youssef, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 5
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Ludovico Abenavoli, Michael Statsenko, Giuseppe Guido Maria Scarlata, et al.
(2024)
Open Access | Times Cited: 1
Ammonia-induced stress response in liver disease progression and hepatic encephalopathy
Rocío Gallego-Durán, Anna Hadjihambi, Javier Ampuero, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 11, pp. 774-791
Closed Access | Times Cited: 1
Inhibition of the urea cycle by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum ammonia levels in mice
Giovan N. Cholico, Russell R. Fling, Warren J. Sink, et al.
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105500-105500
Open Access | Times Cited: 3
Sarcopenia and non-alcoholic fatty liver disease
R. G. Myazin
Experimental and Clinical Gastroenterology (2024), Iss. 2, pp. 120-130
Open Access
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Ludovico Abenavoli, Michael Statsenko, Giuseppe Guido Maria Scarlata, et al.
Livers (2024) Vol. 4, Iss. 4, pp. 495-506
Open Access
Biotransformed bear bile powder alleviates diet-induced nonalcoholic fatty liver disease in mice by regulating the gut microbiota and reversing lipid metabolism
Shan Jiang, Xiaolu Wei, Hongjie Wang, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 2, pp. 105578-105578
Open Access
Page 1

Scroll to top